Terms: = Endocrine gland cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
37 results:
1. Your Family Connects: A Theory-Based Intervention to Encourage Communication about Possible Inherited cancer Risk among Ovarian cancer Survivors and Close Relatives.
Zhao J; McBride CM; Campbell GP; Pentz RD; Escoffery C; Konomos M; Bellcross C; Ward K; Shepperd JR; Guan Y
Public Health Genomics; 2023; 26(1):77-89. PubMed ID: 37487468
[TBL] [Abstract] [Full Text] [Related]
2. Preventing Postoperative Apoplexy in Giant Pituitary Adenomas using Combined Trans-Sphenoidal and Cranial Surgery.
Baldia M; Rajshekhar V
Neurol India; 2023; 71(3):439-446. PubMed ID: 37322737
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
[TBL] [Abstract] [Full Text] [Related]
4. Investigation of the clinical utility of adhesion molecules in the management of thyroid nodules.
Rabi LT; Peres KC; Nascimento M; de Souza Teixeira E; de Freitas LLL; Barreto IS; Geraldo MV; Assumpção LVM; Máximo V; Tincani AJ; Bufalo NE; Ward LS
Sci Rep; 2023 Mar; 13(1):4069. PubMed ID: 36906717
[TBL] [Abstract] [Full Text] [Related]
5. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
[TBL] [Abstract] [Full Text] [Related]
6. The importance of the Peritoneal cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.
Rawert FL; Luengas-Würzinger V; Claßen-Gräfin von Spee S; Baransi S; Schuler E; Carrizo K; Dizdar A; Mallmann P; Lampe B
Arch Gynecol Obstet; 2022 Nov; 306(5):1665-1672. PubMed ID: 35357582
[TBL] [Abstract] [Full Text] [Related]
7. Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of Pancreatic Carcinoma After Curative Resection.
Xu J; Lyu S; Zhao Y; Zhang X; Liu Z; Zhao X; He Q
Technol Cancer Res Treat; 2022; 21():15330338221078438. PubMed ID: 35138217
[No Abstract] [Full Text] [Related]
8. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
[TBL] [Abstract] [Full Text] [Related]
9. A systematic review and network meta-analysis of different surgical approaches for pancreaticoduodenectomy.
Kamarajah SK; Bundred JR; Marc OS; Jiao LR; Hilal MA; Manas DM; White SA
HPB (Oxford); 2020 Mar; 22(3):329-339. PubMed ID: 31676255
[TBL] [Abstract] [Full Text] [Related]
10. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer.
Abraham E; Roshan D; Tran B; Wykes J; Campbell P; Ebrahimi A
J Surg Oncol; 2019 Nov; 120(6):1016-1022. PubMed ID: 31452204
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
[TBL] [Abstract] [Full Text] [Related]
12. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
[TBL] [Abstract] [Full Text] [Related]
13. Useful aspects of diagnosis of imprint cytology in intraoperative consultation of ovarian tumors: comparison between imprint cytology and frozen sections.
Azami S; Aoki Y; Iino M; Sakaguchi A; Ogura K; Ogishima D; Matsumoto T
Diagn Cytopathol; 2018 Jan; 46(1):28-34. PubMed ID: 29034605
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in Thyroid Nodules.
Ahn SH; Park SY; Choi SI
Endocr Pathol; 2017 Dec; 28(4):332-338. PubMed ID: 28748505
[TBL] [Abstract] [Full Text] [Related]
15. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract] [Full Text] [Related]
16. Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion-Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine Tumors.
Klau M; Mayer P; Bergmann F; Maier-Hein K; Hase J; Hackert T; Kauczor HU; Grenacher L; Stieltjes B
Invest Radiol; 2015 Nov; 50(11):792-7. PubMed ID: 26186280
[TBL] [Abstract] [Full Text] [Related]
17. Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer.
Huang P; Zhang Y; Chen J; Shentu W; Sun Y; Yang Z; Liang T; Chen S; Pu Z
Oncotarget; 2015 Aug; 6(24):20241-51. PubMed ID: 26036312
[TBL] [Abstract] [Full Text] [Related]
18. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
Kalra S; Atkinson BJ; Matrana MR; Matin SF; Wood CG; Karam JA; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
BJU Int; 2016 May; 117(5):761-5. PubMed ID: 26032863
[TBL] [Abstract] [Full Text] [Related]
19. Genomic profile of a Li-Fraumeni-like syndrome patient with a 45,X/46,XX karyotype, presenting neither mutations in TP53 nor clinical stigmata of Turner syndrome.
Basso TR; Villacis RA; Canto LM; Alves VM; Lapa RM; Nóbrega AF; Achatz MI; Rogatto SR
Cancer Genet; 2015 Jun; 208(6):341-4. PubMed ID: 25935441
[TBL] [Abstract] [Full Text] [Related]
20. Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.
Barollo S; Pezzani R; Cristiani A; Redaelli M; Zambonin L; Rubin B; Bertazza L; Zane M; Mucignat-Caretta C; Bulfone A; Pennelli G; Casal Ide E; Pelizzo MR; Mantero F; Moro S; Mian C
Thyroid; 2014 May; 24(5):809-19. PubMed ID: 24295088
[TBL] [Abstract] [Full Text] [Related]
[Next]
